4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas

被引：14

作者：

Jiao, Cheng ^{[1
,2
]}

Zvonkov, Eugene ^{[3
]}

Lai, Xun ^{[4
]}

Zhang, Rui ^{[1
]}

Liu, Yuchen ^{[1
]}

Qin, Yue ^{[5
]}

Savchenko, Valery ^{[3
]}

Gabeeva, Nelly ^{[3
]}

Chung, Tsai-Hua ^{[1
,5
]}

Sheng, Liyuan ^{[2
,6
]}

Chang, Lung-Ji ^{[1
,5
]}

机构：

[1] Shenzhen Genoimmune Med Inst, Shenzhen 518000, Peoples R China

[2] PKU HKUST Shenzhen Hong Kong Inst, Shenzhen 518057, Peoples R China

[3] Natl Res Ctr Hematol, Moscow 125167, Russia

[4] Kunming Med Univ, Canc Hosp Yunnan, Affiliated Hosp 3, Kunming 650118, Yunnan, Peoples R China

[5] Univ Elect Sci & Technol China, Chengdu 611731, Sichuan, Peoples R China

[6] Peking Univ, Shenzhen Inst, Shenzhen Key Lab Human Tissue Regenerate Repair, Shenzhen 518057, Peoples R China

来源：

BLOOD CANCER JOURNAL | 2021年 / 11卷 / 03期

关键词：

D O I：

10.1038/s41408-021-00455-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 10 条

[1] Development of adaptive immune effector therapies in solid tumors [J].

Comoli, P. ;

Chabannon, C. ;

Koehl, U. ;

Lanza, F. ;

Urbano-Ispizua, A. ;

Hudecek, M. ;

Ruggeri, A. ;

Secondino, S. ;

Bonini, C. ;

Pedrazzoli, P. .

ANNALS OF ONCOLOGY, 2019, 30 (11) :1740-1750

[2] Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach? [J].

Dunleavy, Kieron ;

Wilson, Wyndham H. .

BLOOD, 2015, 125 (01) :33-39

[3] Chimeric antigen receptor T cell therapy: 25 years in the making [J].

Gill, Saar ;

Maus, Marcela V. ;

Porter, David L. .

BLOOD REVIEWS, 2016, 30 (03) :157-167

[4] How I treat primary mediastinal B-cell lymphoma [J].

Giulino-Roth, Lisa .

BLOOD, 2018, 132 (08) :782-790

[5] Overcoming Antigen Escape with CAR T-cell Therapy [J].

Jackson, Hollie J. ;

Brentjens, Renier J. .

CANCER DISCOVERY, 2015, 5 (12) :1238-1240

[6] Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions [J].

Lees, Charlotte ;

Keane, Colm ;

Gandhi, Maher K. ;

Gunawardana, Jay .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) :25-41

[7] Current Progress in CAR-T Cell Therapy for Solid Tumors [J].

Ma, Shuo ;

Li, Xinchun ;

Wang, Xinyue ;

Cheng, Liang ;

Li, Zhong ;

Zhang, Changzheng ;

Ye, Zhenlong ;

Qian, Qijun .

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (12) :2548-2560

[8] Tumor Antigen Escape from CAR T-cell Therapy [J].

Majzner, Robbie G. ;

Mackall, Crystal L. .

CANCER DISCOVERY, 2018, 8 (10) :1219-1226

[9]

Martinez M, 2019, FRONT IMMUNOL, V10, DOI [10.3389/fimmu.2019.00128, 10.3389/fpsyg.2019.00618]

[10] Enhancing CAR T cell efficacy: the next step toward a clinical revolution? [J].

Namuduri, Manjusha ;

Brentjens, Renier J. .

EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (05) :533-543

← 1 →